These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16188501)

  • 1. Gastrointestinal pharmacology: irritable bowel syndrome.
    Bueno L
    Curr Opin Pharmacol; 2005 Dec; 5(6):583-8. PubMed ID: 16188501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irritable bowel syndrome.
    Mertz HR
    N Engl J Med; 2003 Nov; 349(22):2136-46. PubMed ID: 14645642
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
    Funatsu T; Takeuchi A; Hirata T; Keto Y; Akuzawa S; Sasamata M
    Eur J Pharmacol; 2007 Nov; 573(1-3):190-5. PubMed ID: 17658508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving pathophysiological model of functional gastrointestinal disorders: implications for treatment.
    Mayer EA; Naliboff BD; Chang L
    Eur J Surg Suppl; 2002; (587):3-9. PubMed ID: 16144195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy for irritable bowel syndrome.
    Lacy BE
    N Engl J Med; 2004 Mar; 350(12):1261-3; author reply 1261-3. PubMed ID: 15031865
    [No Abstract]   [Full Text] [Related]  

  • 6. [Genetic background of irritable bowel syndrome].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Jun; 147(25):1167-70. PubMed ID: 16893132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment of irritable bowel syndrome--from concept to sales.
    Kamm MA
    Eur J Surg Suppl; 2002; (587):10-5. PubMed ID: 16144196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy for irritable bowel syndrome.
    Olden KW
    N Engl J Med; 2004 Mar; 350(12):1261-3; author reply 1261-3. PubMed ID: 15028836
    [No Abstract]   [Full Text] [Related]  

  • 9. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
    Kerckhoffs AP; Ter Linde JJ; Akkermans LM; Samsom M
    Neurogastroenterol Motil; 2008 Aug; 20(8):900-7. PubMed ID: 18363639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
    Moskwa A; Boznańska P
    Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy.
    Dobrek Ł; Thor PJ
    Acta Pol Pharm; 2009; 66(5):447-60. PubMed ID: 19894640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irritable bowel syndrome genophenomics: correlation of serotonin-transporter polymorphisms and alosetron response.
    Scherl E; Frissora CL
    Pharmacogenomics J; 2003; 3(2):64-6. PubMed ID: 12746730
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of the irritable bowel syndrome from the point of conclusive medicine].
    Rumiantsev VG
    Eksp Klin Gastroenterol; 2005; (1):32-7, 106. PubMed ID: 15991850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome.
    Van Kerkhoven LA; Laheij RJ; Jansen JB
    Aliment Pharmacol Ther; 2007 Oct; 26(7):979-86. PubMed ID: 17877505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tegaserod for constipation-predominant irritable bowel syndrome.
    Kale-Pradhan PB; Wilhelm SM
    Pharmacotherapy; 2007 Feb; 27(2):267-77. PubMed ID: 17253916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of irritable bowel syndrome.
    Hadley SK; Gaarder SM
    Am Fam Physician; 2005 Dec; 72(12):2501-6. PubMed ID: 16370407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter gene polymorphisms in irritable bowel syndrome.
    Geeraerts B; van Oudenhove L; Tack J
    Neurogastroenterol Motil; 2006 Nov; 18(11):957-9. PubMed ID: 17040405
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease activated receptor 2: a new target for IBS treatment.
    Bueno L
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():95-102. PubMed ID: 18924448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic agents and the irritable bowel syndrome: what goes wrong?
    Spiller R
    Curr Opin Pharmacol; 2008 Dec; 8(6):709-14. PubMed ID: 18672092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.